MENU
PIRS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Pieris Pharmaceuticals (PIRS) Ownership - Who owns Pieris Pharmaceuticals?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
225 Franklin Street
Phone
+1 857 246-8998
Employees
50
Web
https://www.pieris.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
17.96M
P/E Ratio
N/A
Total Cash
19.36M
Projected Growth
N/A
Total Debt
N/A
Revenue
1.35M
Risk (Beta)
0.06
Dividend Yield
N/A
Total Cash/Share
14.67
Total Debt/Equity
N/A
Revenue/Share
1.06 USD as % of share price
Fundamentals
PIRS
Capitalization
18M
P/E Ratio
N/A
Risk (Beta)
0.06
Dividend Yield
N/A
Total Cash
19.4M
Total Cash/Share
14.67
Total Debt
0
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.06%
Revenue
1.35M
ROE
N/A
Book Value
16.3M
P/B Ratio
1.10
Cash Flow
N/A
Earnings
-12.11
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1K
Current Ratio
4.82
Current Revenue Per Employee
1060.00
Dividends Per Share - Security
N/A
EBITDA
-18.1M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-39.93
Shares Held By Institutions
6.75M
Shares Outstanding - Current
1.32M
Total Liabilities
4.25M
Total Volume MTD
N/A
Value
1
Gain YTD
-6.593
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of an anticalin-brand protein technology
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
225 Franklin Street
Phone
+1 857 246-8998
Employees
50
Web
https://www.pieris.com